Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (801-810 of 1,212) with videos related to

Pageof 122
Sort By:
Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.
Reproductive Biomedicine Online|March 20, 2013
Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?R Fleming, F Broekmans, C Calhaz-Jorge, et al.
American Heart Journal|October 27, 2009
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) TrialSana M Al-Khatib, Gail Hafley, Robert A Harrington, et al.
Occupational and Environmental Medicine|May 17, 2014
Mortality and cancer incidence in ammonium perfluorooctanoate production workersKatherine K Raleigh, Bruce H Alexander, Geary W Olsen, et al.
JACC. Advances|November 4, 2024
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and MultimorbidityKonstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal|November 18, 2024
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUSAlexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, et al.
Journal of the National Cancer Institute|June 20, 2002
Breast cancer mortality among female radiologic technologists in the United StatesAparna K Mohan, Michael Hauptmann, Martha S Linet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
Clinical Cardiology|March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosisKenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Pageof 122

Showing results (801-810 of 1,212) with videos related to

Sort By:
Pageof 122
Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.
Reproductive Biomedicine Online|March 20, 2013
Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?R Fleming, F Broekmans, C Calhaz-Jorge, et al.
American Heart Journal|October 27, 2009
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) TrialSana M Al-Khatib, Gail Hafley, Robert A Harrington, et al.
Occupational and Environmental Medicine|May 17, 2014
Mortality and cancer incidence in ammonium perfluorooctanoate production workersKatherine K Raleigh, Bruce H Alexander, Geary W Olsen, et al.
JACC. Advances|November 4, 2024
Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and MultimorbidityKonstantin A Krychtiuk, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal|November 18, 2024
Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUSAlexander C Fanaroff, Amit N Vora, Daniel M Wojdyla, et al.
Journal of the National Cancer Institute|June 20, 2002
Breast cancer mortality among female radiologic technologists in the United StatesAparna K Mohan, Michael Hauptmann, Martha S Linet, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.
Clinical Cardiology|March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosisKenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Pageof 122